Toll-like receptor 4-mediated signaling by epithelial surfaces: Necessity or threat?

Microbes and Infection

Volumn 5, Issue 11, 2003, Pages 951-959

  Bäckhed, Fredrik ^a,b   Hornef, Mathias ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epithelial cells; Lipopolysaccharide; Mucosal immunity; Toll like receptor 4

Indexed keywords

ADAPTOR PROTEIN; CD14 ANTIGEN; HEAT SHOCK PROTEIN 60; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PNEUMOLYSIN; SCLEROPROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR;

ADAPTATION SYNDROME; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; CELL ACTIVATION; CELL COMPARTMENTALIZATION; EPITHELIUM CELL; GASTROINTESTINAL TRACT; GRAM NEGATIVE INFECTION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOMODULATION; MICROFLORA; MOLECULAR MECHANICS; MUCOSAL IMMUNITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROKARYOSIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; SEPSIS; URINARY TRACT;

NEGIBACTERIA;

EID: 0042196011     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00189-8     Document Type: Review

References (86)

1. Shiloh M.U., MacMicking J.D., Nicholson S., Brause J.E., Potter S., Marino M., Fang F., Dinauer M., Nathan C. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity. 10:1999;29-38.
2. Westphal O., Lüderitz O. Chemische Erforschung von Lipopolysacchariden Gram-negativer Bakterien. Angew. Chemie. 66:1954;407-417.
3. Wyckoff T.J., Raetz C.R., Jackman J.E. Antibacterial and anti-inflammatory agents that target endotoxin. Trends Microbiol. 6:1998;154-159.
4. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T., Kuo G.C., Lowry S.F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 330:1987;662-664.
5. Anderson K.V., Bokla L., Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell. 42:1985;791-798.
6. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 86:1996;973-983.
7. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
8. Taguchi T., Mitcham J.L., Dower S.K., Sims J.E., Testa J.R. Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14. Genomics. 32:1996;486-488.
9. Sultzer B.M. Genetic control of leucocyte responses to endotoxin. Nature. 219:1968;1253-1254.
10. O'Brien A.D., Rosenstreich D.L., Taylor B.A. Control of natural resistance to Salmonella typhimurium and Leishmania donovani in mice by closely linked but distinct genetic loci. Nature. 287:1980;440-442.
11. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
12. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:1999;3749-3752.
13. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E., Lowry S.F. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186:2002;1522-1525.
14. Chaudhary P.M., Ferguson C., Nguyen V., Nguyen O., Massa H.F., Eby M., Jasmin A., Trask B.J., Hood L., Nelson P.S. Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans. Blood. 91:1998;4020-4027.
15. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA. 95:1998;588-593.
16. Takeuchi O., Kawai T., Sanjo H., Copeland N.G., Gilbert D.J., Jenkins N.A., Takeda K., Akira S. TLR6: a novel member of an expanding Toll-like receptor family. Gene. 231:1999;59-65.
17. Chuang T.H., Ulevitch R.J. Cloning and characterization of a sub-family of human Toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 11:2000;372-378.
18. Du X., Poltorak A., Wei Y., Beutler B. Three novel mammalian Toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Netw. 11:2000;362-371.
19. Chuang T., Ulevitch R.J. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochem. Biophys. Acta. 1518:2001;157-161.
20. O'Neill L.A. Wanted: a molecular basis for specificity in Toll-like receptor signal transduction. Mol. Cell. 10:2002;969-971.
21. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M. MD-2 a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. M. 189:1999;1777-1782.
22. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14 a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
23. Hornef M.W., Frisan T., Vandewalle A., Normark S., Richter-Dahlfors A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. M. 195:2002;559-570.
24. Tsuboi N., Yoshikai Y., Matsuo S., Kikuchi T., Iwami K., Nagai Y., Takeuchi O., Akira S., Matsuguchi T. Roles of Toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J. Immunol. 169:2002;2026-2033.
25. Song P.I., Abraham T.A., Park Y., Zivony A.S., Harten B., Edelhauser H.F., Ward S.L., Armstrong C.A., Ansel J.C. The expression of functional LPS receptor proteins CD14 and Toll-like receptor 4 in human corneal cells. Invest. Ophthalmol. Vis. Sci. 42:2001;2867-2877.
26. Becker M.N., Diamond G., Verghese M.W., Randell S.H. CD14-dependent lipopolysaccharide-induced β-defensin-2 expression in human tracheobronchial epithelium. J. Biol. Chem. 275:2000;29731-29736.
27. Song P.I., Park Y.M., Abraham T., Harten B., Zivony A., Neparidze N., Armstrong C.A., Ansel J.C. Human keratinocytes express functional CD14 and Toll-like receptor 4. J. Invest. Dermatol. 119:2002;424-432.
28. Schilling J.D., Martin S.M., Hunstad D.A., Patel K.P., Mulvey M.A., Justice S.S., Lorenz R.G., Hultgren S.J. CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect. Immun. 71:2003;1470-1480.
29. Malley R., Henneke P., Morse S.C., Cieslewicz M.J., Lipsitch M., Thompson C.M., Kurt-Jones E., Paton J.C., Wessels M.R., Golenbock D.T. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA. 100:2003;1966-1971.
30. Frendeus B., Wachtler C., Hedlund M., Fischer H., Samuelsson P., Svensson M., Svanborg C. Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol. Microbiol. 40:2001;37-51.
31. Sasu S., LaVerda D., Qureshi N., Golenbock D.T., Beasley D. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via Toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ. Res. 89:2001;244-250.
32. Shoham S., Huang C., Chen J.M., Golenbock D.T., Levitz S.M. Toll-like receptor 4 mediates intracellular signaling without TNF-α release in response to Cryptococcus neoformans polysaccharide capsule. J. Immunol. 166:2001;4620-4626.
33. Wang J.E., Warris A., Ellingsen E.A., Jorgensen P.F., Flo T.H., Espevik T., Solberg R., Verweij P.E., Aasen A.O. Involvement of CD14 and Toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect. Immun. 69:2001;2402-2406.
34. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:2000;398-401.
35. Ohashi K., Burkart V., Flohe S., Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164:2000;558-561.
36. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J., Chow J.C., Strauss J.F. 3rd. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276:2001;10229-10233.
37. Smiley S.T., King J.A., Hancock W.W. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167:2001;2887-2894.
38. Guillot L., Balloy V., McCormack F.X., Golenbock D.T., Chignard M., Si-Tahar M. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168:2002;5989-5992.
39. Lorenz E., Patel D.D., Hartung T., Schwartz D.A. Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide. Infect. Immun. 70:2002;4892-4896.
40. Savage D.C. Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31:1977;107-133.
41. Bäckhed F., Rokbi B., Torstensson E., Zhao Y., Nilsson C., Seguin D., Normark S., Buchan A.M., Richter-Dahlfors A. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J. Infect. Dis. 187:2003;829-836.
42. Abreu M.T., Vora P., Faure E., Thomas L.S., Arnold E.T., Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167:2001;1609-1616.
43. Smith P.D., Smythies L.E., Mosteller-Barnum M., Sibley D.A., Russell M.W., Merger M., Sellers M.T., Orenstein J.M., Shimada T., Graham M.F., Kubagawa H. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J. Immunol. 167:2001;2651-2656.
44. Iwami K.I., Matsuguchi T., Masuda A., Kikuchi T., Musikacharoen T., Yoshikai Y. Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling. J. Immunol. 165:2000;6682-6686.
45. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., Nakanishi K., Kimoto M., Miyake K., Takeda K., Akira S. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J. Immunol. 164:2000;3476-3479.
46. Janssens S., Burns K., Tschopp J., Beyaert R. Regulation of interleukin-1- and lipopolysaccharide-induced NF-κ B activation by alternative splicing of MyD88. Curr. Biol. 12:2002;467-471.
47. Kobayashi K., Hernandez L.D., Galan J.E., Janeway C.A. Jr, Medzhitov R., Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 110:2002;191-202.
48. Arvelo M.B., Cooper J.T., Longo C., Daniel S., Grey S.T., Mahiou J., Czismadia E., Abu-Jawdeh G., Ferran C. A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology. 35:2002;535-543.
49. Ortega-Cava C.F., Ishihara S., Rumi M.A., Kawashima K., Ishimura N., Kazumori H., Udagawa J., Kadowaki Y., Kinoshita Y. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J. Immunol. 170:2003;3977-3985.
50. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167:2001;1882-1885.
51. Hooper L.V., Midtvedt T., Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22:2002;283-307.
52. Weintraub A., Zahringer U., Wollenweber H.W., Seydel U., Rietschel E.T. Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur. J. Biochem. 183:1989;425-431.
53. Golenbock D.T., Hampton R.Y., Qureshi N., Takayama K., Raetz C.R. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J. Biol. Chem. 266:1991;19490-19498.
54. Christ W.J., Asano O., Robidoux A.L., Perez M., Wang Y., Dubuc G.R., Gavin W.E., Hawkins L.D., McGuinness P.D., Mullarkey M.A., et al. E5531, a pure endotoxin antagonist of high potency. Science. 268:1995;80-83.
55. Pohlman T.H., Munford R.S., Harlan J.M. Deacylated lipopolysaccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro. J. Exp. M. 165:1987;1393-1402.
56. Hooper L.V., Gordon J.I. Commensal host-bacterial relationships in the gut. Science. 292:2001;1115-1118.
57. Stappenbeck T.S., Hooper L.V., Gordon J.I. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. USA. 99:2002;15451-15455.
58. Orth K., Palmer L.E., Bao Z.Q., Stewart S., Rudolph A.E., Bliska J.B., Dixon J.E. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science. 285:1999;1920-1923.
59. Collier-Hyams L.S., Zeng H., Sun J., Tomlinson A.D., Bao Z.Q., Chen H., Madara J.L., Orth K., Neish A.S. Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappaB pathway. J. Immunol. 169:2002;2846-2850.
60. Naik S., Kelly E.J., Meijer L., Pettersson S., Sanderson I.R. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J. Pediatr. Gastroenterol. Nutr. 32:2001;449-453.
61. Cario E., Podolsky D.K. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68:2000;7010-7017.
62. Svanborg C., Bergsten G., Fischer H., Frendeus B., Godaly G., Gustafsson E., Hang L., Hedlund M., Karpman D., Lundstedt A.C., Samuelsson M., Samuelsson P., Svensson M., Wullt B. The 'innate' host response protects and damages the infected urinary tract. Ann. M. 33:2001;563-570.
63. Hagberg L., Hull R., Hull S., McGhee J.R., Michalek S.M., Svanborg Eden C. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect. Immun. 46:1984;839-844.
64. Bäckhed F., Soderhall M., Ekman P., Normark S., Richter-Dahlfors A. Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract. Cell Microbiol. 3:2001;153-158.
65. Schilling J.D., Mulvey M.A., Vincent C.D., Lorenz R.G., Hultgren S.J. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J. Immunol. 166:2001;1148-1155.
66. Harding G.K.M., Ronald A.R. The management of urinary tract infections: what have we learned in the past decade? Int. J. Antimicrob. Agents. 4:1994;83-88.
67. Johnson J.R. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4:1991;80-128.
68. Bäckhed F., Meijer L., Normark S., Richter-Dahlfors A. TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14. Cell Microbiol. 4:2002;493-503.
69. Hedlund M., Wachtler C., Johansson E., Hang L., Somerville J.E., Darveau R.P., Svanborg C. P. fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses. Mol. Microbiol. 33:1999;693-703.
70. Hedlund M., Frendeus B., Wachtler C., Hang L., Fischer H., Svanborg C. Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells. Mol. Microbiol. 39:2001;542-552.
71. Wolfs T.G., Buurman W.A., van Schadewijk A., de Vries B., Daemen M.A., Hiemstra P.S., van't Veer C. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-γ and TNF-α mediated up-regulation during inflammation. J. Immunol. 168:2002;1286-1293.
72. Miettinen M., Sareneva T., Julkunen I., Matikainen S. IFNs activate Toll-like receptor gene expression in viral infections. Genes Immun. 2:2001;349-355.
73. Abreu M.T., Arnold E.T., Thomas L.S., Gonsky R., Zhou Y., Hu B., Arditi M. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J. Biol. Chem. 277:2002;20431-20437.
74. Uehara A., Sugawara S., Takada H. Priming of human oral epithelial cells by interferon-γ to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids and peptidoglycans. J. Med. Microbiol. 51:2002;626-634.
75. Ruemmele F.M., Beaulieu J.F., Dionne S., Levy E., Seidman E.G., Cerf-Bensussan N., Lentze M.J. Lipopolysaccharide modulation of normal enterocyte turnover by Toll-like receptors is mediated by endogenously produced tumour necrosis factor α Gut. 51:2002;842-848.
76. Uehara A., Sugawara S., Tamai R., Takada H. Contrasting responses of human gingival and colonic epithelial cells to lipopolysaccharides, lipoteichoic acids and peptidoglycans in the presence of soluble CD14. Med. Microbiol. Immunol. (Berlin). 189:2001;185-192.
77. Asai Y., Ohyama Y., Gen K., Ogawa T. Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect. Immun. 69:2001;7387-7395.
78. Schwartz D.A. The role of TLR4 in endotoxin responsiveness in humans. J. Endotoxin Res. 7:2001;389-393.
79. Schulz C., Farkas L., Wolf K., Kratzel K., Eissner G., Pfeifer M. Differences in LPS-induced activation of bronchial epithelial cells (BEAS-2B) and type II-like pneumocytes (A-549). Scand. J. Immunol. 56:2002;294-302.
80. Kawahara T., Teshima S., Oka A., Sugiyama T., Kishi K., Rokutan K. Type I Helicobacter pylori lipopolysaccharide stimulates Toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect. Immun. 69:2001;4382-4389.
81. Maeda S., Akanuma M., Mitsuno Y., Hirata Y., Ogura K., Yoshida H., Shiratori Y., Omata M. Distinct mechanism of Helicobacter pylori-mediated NF-κ B activation between gastric cancer cells and monocytic cells. J. Biol. Chem. 276:2001;44856-44864.
82. Bocker U., Yezerskyy O., Feick P., Manigold T., Panja A., Kalina U., Herweck F., Rossol S., Singer M.V. Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. Int. J. Colorectal Dis. 18:2003;25-32.
83. Cario E., Rosenberg I.M., Brandwein S.L., Beck P.L., Reinecker H.C., Podolsky D.K. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol. 164:2000;966-972.
84. Cario E., Brown D., McKee M., Lynch-Devaney K., Gerken G., Podolsky D.K. Commensal-associated molecular patterns induce selective Toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am. J. Pathol. 160:2002;165-173.
85. Fichorova R.N., Cronin A.O., Lien E., Anderson D.J., Ingalls R.R. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of Toll-like receptor 4-mediated signaling. J. Immunol. 168:2002;2424-2432.
86. Muenzner P., Billker O., Meyer T.F., Naumann M. Nuclear factor-κ B directs carcinoembryonic antigen-related cellular adhesion molecule 1 receptor expression in Neisseria gonorrhoeae-infected epithelial cells. J. Biol. Chem. 277:2002;7438-7446.